U.S Pacemaker Market to reach $3.4 billion by 2030; Increasing prevalence of cardiovascular diseases, Technological advancements in pacemaker technology and design, rise in demand for minimally invasive procedures and development of healthcare infras

The U.S Pacemaker Market size is estimated to reach $3.4 billion by 2030, growing at a CAGR of 4.9% during the forecast period 2024-2030, according to a recent report published by IndustryARC, titled, “U.S Pacemaker Market - By Type (MRI Compatible Pacemaker and Conventional Pacemaker), By Technology (Leadless pacemaker, Single-chamber pacemaker, Dual-chamber pacemaker and Biventricular pacemaker), By Implantability (Implantable Pacemaker and External Pacemaker), By Application (Bradycardia, Tachy-brady syndrome, Arrhythmias, Heart block, Tachycardia and Others), By End User (Hospitals & Cardiac Centers and Ambulatory Surgical Centers) Opportunity Analysis & Industry Forecast, 2024-2030.” 

The main driver of the U.S Pacemaker market is increasing prevalence of cardiovascular diseases in the region. By regulating the heart’s rhythm, a pacemaker can often eliminate the symptoms of bradycardia. This means individuals often have more energy and less shortness of breath. Additionally, technological advancements and rise in demand for minimally invasive procedures are propelling the growth of the U.S Pacemaker market. 

The MRI compatible pacemaker segment dominated the U.S Pacemaker market in 2023. The number of magnetic resonance imaging (MRI) procedures is growing annually as a result of improved access and growing cardiac and noncardiac reasons. Cardiac implantable electronic devices (CIEDs) have become more popular due to the same factors. One in two CIED patients are predicted to need an MRI after the device is implanted. Because of the possibility of interactions with CIED components that result in mechanical force and torque, overheating of CIED components, current induction that causes myocardial capture at fast rates, power-on resets that inappropriately inhibit pacing and/or delivery of tachytherapies, and CIED malfunction or loss of function, the magnetic field produced by an MRI scanner has raised safety concerns. For instance, In December 2024, Abbott announced the successful completion of the world's first in-human leadless left bundle branch area pacing (LBBAP) procedures using its investigational AVEIR Conduction System Pacing (CSP) leadless pacemaker. These procedures, part of a feasibility study, mark the first implantation of a leadless pacemaker in the heart's left bundle branch area, aiming to mimic the heart's natural rhythm. The study evaluates the acute safety and performance of this innovative system, offering a potential new treatment for individuals with slow heart rhythms. Such advancements are driving the growth of the market. 

The rise in number of cardiovascular diseases is propelling the growth of the U.S Pacemaker market significantly. For instance, according to a report from the American Heart Association 2024, The overall number of cardiovascular related deaths was 931,578, an increase of less than 3,000 from the 928,741 deaths reported in 2023.Cardiovascular deaths include deaths from coronary heart disease (40.3%), stroke (17.5%), other minor CVD causes combined (17.1%), high blood pressure (13.4%), heart failure (9.1%) and diseases of the arteries (2.6%). The report also revealed that approximately every 40 seconds, someone in the U.S. will have a heart attack. Each year in the U.S., there are about 605,000 new heart attacks and 200,000 recurrent attacks. Of these, it is estimated that 170,000 are silent, without significant symptoms. Such factors are mandating the need of advanced treatments and equipment such as pacemaker, which in turn driving the growth of the market. 

Technological advancements in the manufacturing of pacemakers are driving the growth of the U.S pacemaker market. For instance, In January 2024, Medtronic announced it had received CE Mark approval for its Micra AV2 and Micra VR2, the latest generation of its miniature, leadless pacemakers. These devices offer longer battery life 16 and 17 years respectively—easier programming, and the benefits of leadless pacing, such as fewer complications compared to traditional pacemakers. Most patients may only need one device for life. The Micra pacemakers also feature remote monitoring, enabling doctors to track the device without in-person visits, reducing hospitalizations and improving patient convenience. This approval follows U.S. FDA clearance in 2023. Such technological advancements are fueling the growth of the U.S Pacemaker market. 

 

Key companies profiled in the U.S Pacemaker Market are Medtronic, Abbott, Boston Scientific Corporation, Biotronik, MicroPort Scientific Corporation, OSCOR Inc, LivaNova, Inc., Teleflex Incorporated, OSYPKA MEDICAL, Sorin Medical Group and Others.  

Cryotherapy & Cryosurgery Market - According to the report analysis by IndustryARC’s expertise, the Cryotherapy & Cryosurgery Market Size is forecast to reach $4,342.70 Million by 2030, at a CAGR of 6.90% during forecast period 2024-2030.One of the major growth factors of the cryotherapy and cryosurgery market is the minimal post-surgery risk to untargeted body parts as well as less wounds and pain as compared to open surgery and other medical treatments. 

Biomedical Sensor Market - The Biomedical Sensor Market Size is forecast to reach $ 20130.0 Million by 2030, at a CAGR of 7.5% during forecast period 2024-2030. The growing need to detect diseases and pathogens at early stages coupled with providing better medical assistance to decrease the fatality rates supplemented by superior medical diagnosis and treatment have been the key drivers for the Biomedical Sensors Industry for the projected period of 2024-2030.  

Oral Care Market - Oral Care Market Size is forecast to reach $ 54200 Million by 2030, at a CAGR of 6.70% during forecast period 2024-2030.Globally, around 6,139,481 oral care products are imported in a year. Rising pediatric and geriatric dental problems, owing to changing lifestyles and modern food habits, is majorly influencing the global oral care market.